» Articles » PMID: 6602200

Role of Interleukin 1 in Anti-immunoglobulin-induced B Cell Proliferation

Overview
Journal J Exp Med
Date 1983 May 1
PMID 6602200
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

In this report we describe conditions for polyclonal activation of small numbers of highly purified mouse B lymphocytes. Three signals are required for induction of DNA synthesis by the particular subset of small B lymphocytes investigated: a signal delivered by antibodies specific for the IgM receptor expressed on the B cell membrane; a signal delivered by a T cell-derived factor (B cell growth factor [BCGF]); and a signal delivered by the macrophage-derived factor interleukin 1 (IL-1). The conclusion that IL-1 has B cell co-stimulator activity is based on the findings that highly purified preparations of mouse and human IL-1 have the capacity to cause proliferation in B cells treated with anti-IgM and BCGF. Such cultures show an absolute dependence on exogenously added IL-1 when 2-mercaptoethanol is omitted from the medium. BCGF and IL-1 each act in a non-antigen-specific, non-H-2-restricted, synergistic manner. Their requirement is not observed when B cells are cultured at high density, presumably reflecting accessory cell contamination and endogenous factor production under these conditions. The B cell activation induced by these three signals is restricted to proliferation without the production of antibody-forming cells.

Citing Articles

Toward a Molecular Understanding of Adaptive Immunity: A Chronology, Part III.

Smith K Front Immunol. 2014; 5:29.

PMID: 24550914 PMC: 3912840. DOI: 10.3389/fimmu.2014.00029.


Quantification of interleukin-1 in nasal polyps from patients with chronic sinusitis.

Liu Y, Hamaguchi Y, Taya M, Sakakura Y Eur Arch Otorhinolaryngol. 1993; 250(2):123-5.

PMID: 8507466 DOI: 10.1007/BF00179312.


Interleukins for B lymphocytes.

Howard M Surv Immunol Res. 1983; 2(3):210-2.

PMID: 6609394 DOI: 10.1007/BF02918413.


Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays.

Swain S, Howard M, Kappler J, Marrack P, Watson J, Booth R J Exp Med. 1983; 158(3):822-35.

PMID: 6604127 PMC: 2187105. DOI: 10.1084/jem.158.3.822.


Primary in vitro plaque-forming cell response to DAGG-Ficoll: LPS-induced enhancement mediated by interleukin-1.

Curtis J, Nordin A Immunology. 1984; 52(4):711-9.

PMID: 6378771 PMC: 1454635.


References
1.
Adinolfi M, Gardner B, Giannelli F, McGuire M . Studies on human lymphocytes stimulated in vitro with anti-gamma and anti-mu antibodies. Experientia. 1967; 23(4):271-2. DOI: 10.1007/BF02135679. View

2.
Gery I, GERSHON R, Waksman B . Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. J Exp Med. 1972; 136(1):128-42. PMC: 2139184. DOI: 10.1084/jem.136.1.128. View

3.
Diener E, Feldmann M . Relationship between antigen and antibody-induced suppression of immunity. Transplant Rev. 1972; 8:76-103. DOI: 10.1111/j.1600-065x.1972.tb01565.x. View

4.
Coutinho A, Moller G . Editorial: Immune activation of B cells: evidence for 'one nonspecific triggering signal' not delivered by the Ig receptors. Scand J Immunol. 1974; 3(2):133-46. View

5.
Wood D, Gaul S . Enhancement of the humoral response of T cell-depleted murine spleens by a factor derived from human monocytes in vitro. J Immunol. 1974; 113(3):925-33. View